Everything below concerns somatotroph. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-25. Numbers and descriptions here follow the published literature rather than marketing material.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
Throughout the 1970s, Bakker built a headquarters for PTL in the Carolinas called Heritage Village. Over time, the Bakkers expanded the ministry to include the Heritage USA theme park in Fort Mill, South Carolina, which became the third most successful theme park in the U.S. at the time. Viewer contributions were estimated to exceed $1 million a week, with proceeds to expand the theme park and The PTL Club's mission. Bakker responded to inquiries about his use of mass media by saying: "I believe that if Jesus were alive today, he would be on TV". Two scandals brought down PTL in 1987: Bakker was accused of sexual misconduct by church secretary Jessica Hahn, which led to his resignation, and his alleged illegal misuse of ministry funds eventually led to his imprisonment. Bakker was dismissed as an Assemblies of God minister on May 6, 1987. In 1990, the biographic television movie Fall from Grace, starring Kevin Spacey as Bakker, depicted his rise and fall. On January 18, 2019, ABC's 20/20 aired a two-hour special, entitled Unfaithfully Yours, about the PTL scandal.
When supported by external democratic actors, coup leaders have an incentive to push for elections to retain external support and consolidate domestic legitimacy. When condemned, coup leaders are apt to trend toward authoritarianism to assure their survival. But coup conspirators also increasingly say that they chose a coup to save their country from the autocratic incumbents. Successful conspirators may hold free and fair elections simply because they think it is a good idea. A desire for economic growth and legitimacy have also been cited as motivations for democratization. Legal scholar Ilya Somin believes that a coup to forcibly overthrow a democratic government might sometimes be justified. Commenting on the 2016 Turkish coup d'état attempt, Somin opined,
Studies have shown that various immunological and autoimmune diseases are much less common in the developing world than in the industrialized world, and that immigrants to the industrialized world from the developing world increasingly develop immunological disorders in relation to the length of time since arrival in the industrialized world. Longitudinal studies in the third world demonstrate an increase in immunological disorders as a country grows more affluent and, it is presumed, cleaner. The use of antibiotics in the first year of life has been linked to asthma and other allergic diseases. The use of antibacterial cleaning products has also been associated with a higher incidence of asthma, as has birth by caesarean section rather than vaginal birth.
Sources: en.wikipedia.org
November 1972); novelist, editor; placed 60th on the Independent on Sunday Pink List 2007; professor of creative writing at Royal Holloway, University of London; correspondent at the New Yorker; became a Fellow of the Royal Society of Literature in 2018; awards and nominations include John Llewellyn Rhys Prize, Somerset Maugham Award, Sunday Times 'Young Writer of the Year (shortlisted), London Arts New London Writers' Award, K. Blundell Trust Award, Le Prince Maurice Roman d'Amour Prize (shortlisted), Geoffrey Faber Memorial Prize (shortlisted), Man Booker Prize 2013 (longlisted) Baileys Women's Prize for Fiction 2014 (longlisted), Women's Prize for Fiction 2022 (longlisted for The Exhibitionist) Heather Mendick, Labour activist previously appointed as Jeremy Corbyn's Jewish liaison officer; former Hackney South constituency Labour party secretary, academic, previously Reader in Education at Brunel University and author of scholarly texts and monographs on educational theory, semantics, science, contemporary culture, ontology, ideology and epistemology, published by Routledge and McGraw Hill Education Farah Mendlesohn (b. 27 July 1968) is a British academic historian, best known for her writings on science fiction and fantasy. Gerard Menuhin, son of Yehudi Menuhin; grandson of leading anti-Zionist activist and scholar, Moshe Menuhin, and from the ancestral lineage of Rabbi Shneur Zalman of Liadi, the founder of Chabad Hassidism as well as Rabbi Levi Yitzchok of Berditchev.
=== Prenatal development === The prenatal portion of tissue-resident dermal macrophages is produced from yolk-sac derived precursors. The generation of dermal macrophages results from primitive haematopoiesis or definitive haematopoiesis. Primitive haematopoiesis allows the generation of yolk-sac derived macrophages and subsequent release into the foetal bloodstream for tissue infiltration and colonisation. The infiltration of the skin by yolk-sac derived macrophages occurs as soon as 8.5 days after fertilisation. Different gene expressions regulate this process. It is independent of the MYB gene and dependent on the PU.1 gene. Definitive haematopoiesis occurs from 11 days and onwards after fertilisation. Monocytes are produced from haematopoietic stem cells in the liver, and they subsequently infiltrate the skin via the foetal bloodstream. In this process, cytokines like CSF1 are essential in facilitating the differentiation of monocytes into tissue-resident dermal macrophages and their survival. Therefore, the differentiation of monocytes to dermal macrophages is CSF-1/CSF1R dependent. The level of dermal macrophages from prenatal development remains detectible through constant, slow proliferation.
== Further reading == Agulhon, Maurice. The Republican Experiment, 1848–1852 (The Cambridge History of Modern France) (1983) excerpt and text search Amann, Peter H. "Writings on the Second French Republic." Journal of Modern History 34.4 (1962): 409–429. Clark, Christopher (2023). Revolutionary Spring: Fighting for a New World 1848–1849. Penguin Random House. Furet, François. Revolutionary France 1770–1880 (1995), pp 385–437. survey of political history by leading scholar Guyver, Christopher, The Second French Republic 1848–1852: A Political Reinterpretation, New York: Palgrave, 2016 Price, Roger, ed. Revolution and reaction: 1848 and the Second French Republic (Taylor & Francis, 1975). Price, Roger. The French Second Republic: A Social History (Cornell UP, 1972).
Sources: en.wikipedia.org
The hypothalamus is commonly known as an integration center of the brain because of its role in integrating inputs from all areas of the brain and producing a specific response. In the neuroendocrine system, the hypothalamus receives electrical signals from different parts of the brain and translates those electrical signals into chemical signals in the form of hormones or releasing factors. These chemicals are then transported to the pituitary gland and from there to the systemic circulation.
Androgen receptors Calcitriol receptors Corticotropin-releasing hormone receptor 1 Corticotropin releasing hormone receptor 2 Estrogen receptors Follicle-stimulating hormone receptors Glucagon receptors Gonadotropin receptors Gonadotropin-releasing hormone receptors Growth hormone receptors Insulin receptor Luteinizing hormone Progesterone receptors Retinoid receptors Somatostatin receptors Thyroid hormone receptors Thyrotropin receptors
=== Preadaptation model === The preadaptation model of de novo gene birth uses mathematical modeling to show that when sequences that are normally hidden are exposed to weak or shielded selection, the resulting pool of "cryptic" sequences (i.e. proto-genes) can be purged of "self-evidently deleterious" variants, such as those prone to lead to protein aggregation, and thus enriched in potential adaptations relative to a completely non-expressed and unpurged set of sequences. This revealing and purging of cryptic deleterious non-genic sequences is a byproduct of pervasive transcription and translation of intergenic sequences, and is expected to facilitate the birth of functional de novo protein-coding genes. This is because by eliminating the most deleterious variants, what is left is, by a process of elimination, more likely to be adaptive than expected from random sequences. Using the evolutionary definition of function (i.e. that a gene is by definition under purifying selection against loss), the preadaptation model assumes that "gene birth is a sudden transition to functionality" that occurs as soon as an ORF acquires a net beneficial effect. In order to avoid being deleterious, newborn genes are expected to display exaggerated versions of genic features associated with the avoidance of harm. This is in contrast to the proto-gene model, which expects newborn genes to have features intermediate between old genes and non-genes.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.